Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 3, 2009, Pages 312-318

  Li, Hong ^a   Shi, Sa ^a   Sun, Yi Hua ^a   Zhao, Ya Jun ^a   Li, Quan Feng ^a   Li, Hong Zhu ^a   Wang, Rui ^b   Xu, Chang Qing ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b LAKEHEAD UNIVERSITY   (Canada)

Author keywords

Cardiomyocytes; Dopamine D2 receptor; Hypertrophy; Rat

Indexed keywords

ANGIOTENSIN II; BROMOCRIPTINE; CALCIUM ION; DOPAMINE 2 RECEPTOR; ENDOTHELIN 1; HALOPERIDOL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL SIZE; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MUSCLE HYPERTROPHY; NEWBORN; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT;

ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; BROMOCRIPTINE; CALCIUM SIGNALING; CARDIOMEGALY; CELLS, CULTURED; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; ENDOTHELIN-1; HALOPERIDOL; HEART VENTRICLES; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2;

EID: 61349157968     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.05064.x     Document Type: Article

References (38)

1. Bunzow JR, Van Tol HH, Grandy DK et al. Cloning and expression of a rat D2 dopamine receptor cDNA. Nature 1988 336 : 783 7.
2. Dive A, Foret F, Jamart J, Bulpa P, Installé E. Effect of dopamine on gastrointestinal motility during critical illness. Intens. Care Med. 2000 26 : 901 7.
3. Sealfon SC, Olanow CW. Dopamine receptors: From structure to behavior. Trends Neurosci. 2000 23 : 34 40.
4. Jose PA, Eisner GM, Felder R. Regulation of blood pressure by dopamine receptors. Nephron Physiol. 2003 95 : 19 27.
5. Anita S, Hyman BN. Coupling of dopamine receptor subtypes to multiple and diverse G proteins. Int. J. Dev. Neurosci. 2000 18 : 669 77.
6. Lee KH, Blaha CD, Harris BT et al. Dopamine efflux in the rat striatum evoked by electrical stimulation of the subthalamic nucleus: Potential mechanism of action in Parkinson's disease. Eur. J. Neurosci. 2006 23 : 1005 14.
7. Johanson CE, Frey KA, Lundahl LH et al. Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology 2006 185 : 327 38.
8. Noble EP. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: A review. Eur. Psychiatry 2000 15 : 79 89.
9. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: From structure to function. Physiol. Rev. 1998 78 : 189 224.
10. Vallone D, Picetti R, Borrelli E. Structure and function of dopamine receptors. Neurosci. Biobehav. Rev. 2000 24 : 125 32.
11. + channels reduces autonomous activity in striatal cholinergic interneurons. J. Neurosci. 2004 24 : 10 289 301.
12. Molkentin JD, Lu JR, Antos CL et al. A calcineurin dependent transcriptional pathway for cardiac hypertrophy. Cell 1998 93 : 215 28.
13. Martin P, Detlev G. The molecular basis of cardiovascular hypertrophy: The role of the rennin-angiotensin system. J. Cardiovasc. Pharmacol. 1992 19 : 51 8.
14. Ueyama T, Kawashima S, Sakada T et al. Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy. J. Mol. Cell. Cardiol. 2000 32 : 947 60.
15. Oriji GK. Angiotensin II stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes: Roles of PKC and PGF-alpha. Prostaglandins Leukot. Essent. Fatty Acids 2000 62 : 233 7.
16. Saito S, Frank GD, Motley ED et al. Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation. Biochem. Biophys. Res. Commun. 2002 294 : 1023 9.
17. Page C, Doubell AF. Mitogen-activated protein kinase (MAPK) in cardiac tissues. Mol. Cell. Biochem. 1996 151 : 49 57.
18. Kodama H, Fukuda K, Pan J et al. Significance of ERK cascade compared with JAK/STAT and PI3-K pathway in gp130-mediated cardiac hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 2000 279 : 1635 44.
19. Li H, Xu CQ, Sun YH et al. Expression profile of DR1, DR2 protein in rat pathological cardiac hypertrophy. J. Pathophysiol. 2006 22 : 1373 7.
20. Li HZ, Han LP, Jiang CM et al. Effect of dopamine receptor 1 on apoptosis of cultured neonatal rat cardiomyocytes in simulated ischaemia/reperfusion. Basic Clin. Pharmacol. Toxicol. 2008 102 : 329 36.
21. Chesley A, Lundberg MS, Asai T et al. The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3′-kinase. Circ. Res. 2000 87 : 1172 9.
22. Hartree EF. Determination of protein: A modification of the Lowry method that gives a linear photometric response. Anal. Biochem. 1972 48 : 422 7.
23. Masao T, Koichi N, Hironori N et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J. Clin. Invest. 2001 108 : 1429 37.
24. Mejía-Rodríguez O, Alvarez-Aguilar C, Vega-Gómez HE, Belio-Caro F, Vargas-Espinosa JM, Paniagua-Sierra JR. Bromocriptine induces regression of left ventricular hypertrophy in peritoneal dialysis patients. Proc. West. Pharmacol. Soc. 2005 48 : 122 5.
25. Basu S, Dasgupta PS. Decreased dopamine receptor expression and its second-messenger cAMP in malignant human colon tissue. Dig. Dis. Sci. 1999 44 : 916 21.
26. Jackson DM, Westlind-Danielsson A. Dopamine receptors: Molecular biology, biochemistry and behavioural aspects. Pharmacol. Ther. 1994 64 : 291 370.
27. Miyazawa T, Matsumoto M, Kato S, Takeuchi K. Dopamine-induced protection against indomethacin-evoked intestinal lesions in rats: Role of anti-intestinal motility mediated by D2 receptors. Med. Sci. Monit. 2003 9 : 71 7.
28. Aplin M, Christensen GL, Schneider M et al. Differential extracellular signal-regulated kinases 1 and 2 activation by the angiotensin type 1 receptor supports distinct phenotypes of cardiac myocytes. Basic Clin. Pharmacol. Toxicol. 2007 100 : 296 301.
29. Aoki H, Richmond M, Izumo S, Sadoshima J. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro. Biochem. J. 2000 347 : 275 84.
30. Rafałowska U, Sulkowski G, Waśekiewicz J, Januszewski S, Kapuościñski A. Alteration of dopamine transport and dopamine D(2) receptor binding in the brain induced by early and late consequences of global ischaemia caused by cardiac arrest in the rat. Resuscitation 2000 47 : 195 201.
31. Masson S, Chimenti S, Salio M et al. CHF-1024a DA2/alpha2 agonist, blunts norepinephrine excretion and cardiac fibrosis in pressure overload. Cardiovasc. Drugs Ther. 2001 15 : 131 8.
32. Hussain T, Abdul-Wahab R, Kotak DK, Lokhandwala MF. Bromocriptine regulates angiotensin II response on sodium pump in proximal tubules. Hypertension 1998 32 : 1054 9.
33. Lahlou S, Lima GC, Leão-Filho CS, Duarte GP. Effects of long-term pretreatment with isoproterenol on bromocriptine-induced tachycardia in conscious rats. Can. J. Physiol. Pharmacol. 2000 78 : 260 5.
34. Ganguly PK, Mukherjee K, Sahai A. Renal dopamine receptors are involved in the development of cardiac hypertrophy. Mol. Cell. Biochem. 1995 44 : 81 4.
35. i. Neurosci. Lett. 1990 112 : 205 9.
36. 2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway. J. Neurophysiol. 1997 77 : 1003 15.
37. Sarkar C, Chakroborty D, Mitra RB, Banerjee S, Dasgupta PS, Basu S. Dopamine in vivo inhibits VEGF-induced phosphorylation of VEGFR-2, MAPK, and focal adhesion kinase in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2004 287 : 1554 60.
38. Miyawaki H, Zhao XB, Ashraf M. Calcium preconditioning elicits strong protection against ischemic injury via protein kinase C signaling pathway. Circ. Res. 1996 79 : 137 46.